Controlled Trial of Nimodipine in Acute Ischemic Stroke

Completed

Phase N/A Results

Summary of Purpose

To determine whether treatment with a calcium-channel blocker would improve survival and neurologic outcome in acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 October 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Bayer AG

Trial Design

Prospective, double-blind, randomized, placebo-controlled trial involving 186 patients at 4 regional hospitals.

Contacts

Not available